VALERIE RUMPLE: Open Payments
NPI 1174706691 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 33 payments from 10 companies in 2025. Trend: 2023 $1,797 · 2024 $1,649 · 2025 $1,931
Travel & lodging: $1,029Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $1,029 |
| Axsome Therapeutics, Inc. | 9 | $255 |
| ABBVIE INC. | 6 | $183 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Noven Therapeutics, LLC | 4 | $91 |
| Janssen Pharmaceuticals, Inc | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 1 | $40 |
| Lundbeck LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: Auvelity, VRAYLAR, REXULTI, TRINTELLIX, Xelstrym, SPRAVATO, COBENFY, Jornay PM.
Industry payments across IN — which companies pay providers there.
